Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(12):1661–1666. doi: 10.1038/bjc.1997.614

Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96.

N Niitsu 1, S Iki 1, K Muroi 1, S Motomura 1, M Murakami 1, H Takeyama 1, A Ohsaka 1, A Urabe 1
PMCID: PMC2228212  PMID: 9413959

Abstract

Twenty cases of interstitial pneumonia secondary to treatment with granulocyte colony-stimulating factor (G-CSF) were reviewed. Their interstitial pneumonia had the following features: (a) it occurred predominantly in patients aged 60 years or older; (b) it was prevalent among patients with haematological malignancies, particularly non-Hodgkin's lymphoma; (c) in all patients G-CSF was given after anti-cancer agents with potential to affect the lungs; (d) at the onset, many patients had symptoms such as dyspnoea and fever; and (e) the leucocyte (neutrophil) count as well as lactate dehydrogenase (LDH) and C-reactive protein (CRP) levels were usually higher than normal at the onset. These findings indicate that, when G-CSF is used in combination with pneumotoxic anti-cancer agents, respiratory function should be monitored before and during treatment. If the leucocyte (or neutrophil) count and/or LDH and CRP increase suddenly in association with dyspnoea and fever during administration of G-CSF, interstitial pneumonia should be suspected. Accordingly, a chest radiograph and pulmonary functional tests should be performed promptly. If a diagnosis of interstitial pneumonia is made, steroid pulse therapy should be commenced immediately.

Full text

PDF
1662

Images in this article

1665Figure 1
on p.1665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bastion Y., Reyes F., Bosly A., Gisselbrecht C., Yver A., Gilles E., Maral J., Coiffier B. Possible toxicity with the association of G-CSF and bleomycin. Lancet. 1994 May 14;343(8907):1221–1222. doi: 10.1016/s0140-6736(94)92426-0. [DOI] [PubMed] [Google Scholar]
  2. Dirix L. Y., Schrijvers D., Druwè P., Van den Brande J., Verhoeven D., Van Oosterom A. T. Pulmonary toxicity and bleomycin. Lancet. 1994 Jul 2;344(8914):56–56. doi: 10.1016/s0140-6736(94)91076-6. [DOI] [PubMed] [Google Scholar]
  3. Idell S., Kucich U., Fein A., Kueppers F., James H. L., Walsh P. N., Weinbaum G., Colman R. W., Cohen A. B. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Nov;132(5):1098–1105. doi: 10.1164/arrd.1985.132.5.1098. [DOI] [PubMed] [Google Scholar]
  4. Iki S., Yoshinaga K., Ohbayashi Y., Urabe A. Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF--clinical attention. Ann Hematol. 1993 Apr;66(4):217–218. doi: 10.1007/BF01703240. [DOI] [PubMed] [Google Scholar]
  5. Katoh M., Shikoshi K., Takada M., Umeda M., Tsukahara T., Kitagawa S., Shirai T. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor. Ann Hematol. 1993 Oct;67(4):201–202. doi: 10.1007/BF01695869. [DOI] [PubMed] [Google Scholar]
  6. Laver J., Moore M. A. Clinical use of recombinant human hematopoietic growth factors. J Natl Cancer Inst. 1989 Sep 20;81(18):1370–1382. doi: 10.1093/jnci/81.18.1370. [DOI] [PubMed] [Google Scholar]
  7. Lei K. I., Leung W. T., Johnson P. J. Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma. Br J Cancer. 1994 Nov;70(5):1009–1013. doi: 10.1038/bjc.1994.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Matthews J. H. Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease: possible synergy. Lancet. 1993 Oct 16;342(8877):988–988. doi: 10.1016/0140-6736(93)92033-p. [DOI] [PubMed] [Google Scholar]
  9. Ohsaka A., Kitagawa S., Sakamoto S., Miura Y., Takanashi N., Takaku F., Saito M. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood. 1989 Dec;74(8):2743–2748. [PubMed] [Google Scholar]
  10. Ohsaka A., Saionji K., Sato N., Mori T., Ishimoto K., Inamatsu T. Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Haematol. 1993 Aug;84(4):574–580. doi: 10.1111/j.1365-2141.1993.tb03130.x. [DOI] [PubMed] [Google Scholar]
  11. Okubo Y., Nakazawa K. [Recombinant G-CSF and the interstitial pneumonia during MACOP-B therapy in two cases of non-Hodgkin's lymphoma]. Rinsho Ketsueki. 1993 Apr;34(4):473–477. [PubMed] [Google Scholar]
  12. Pettengell R., Gurney H., Radford J. A., Deakin D. P., James R., Wilkinson P. M., Kane K., Bentley J., Crowther D. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood. 1992 Sep 15;80(6):1430–1436. [PubMed] [Google Scholar]
  13. Sausville E. A., Peisach J., Horwitz S. B. Effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry. 1978 Jul 11;17(14):2740–2746. doi: 10.1021/bi00607a007. [DOI] [PubMed] [Google Scholar]
  14. Tazi A., Nioche S., Chastre J., Smiéjan J. M., Hance A. J. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am J Respir Cell Mol Biol. 1991 Feb;4(2):140–147. doi: 10.1165/ajrcmb/4.2.140. [DOI] [PubMed] [Google Scholar]
  15. Weiland J. E., Davis W. B., Holter J. F., Mohammed J. R., Dorinsky P. M., Gadek J. E. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis. 1986 Feb;133(2):218–225. doi: 10.1164/arrd.1986.133.2.218. [DOI] [PubMed] [Google Scholar]
  16. Wiley J. S., Jamieson G. P., Cebon J. S., Woodruff R. K., McKendrick J. J., Szer J., Gibson J., Sheridan W. P., Biggs J. C., Rallings M. C. Cytokine priming of acute myeloid leukemia may produce a pulmonary syndrome when associated with a rapid increase in peripheral blood myeloblasts. Blood. 1993 Dec 1;82(11):3511–3512. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES